Despite hype, private payers slow to adopt oncology value-based models

Published: Jan 19, 2018
Abstract
Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic...
Paper Details
Title
Despite hype, private payers slow to adopt oncology value-based models
Published Date
Jan 19, 2018
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.